# cognivue

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed August 9, 2026.

> Cognivue provides FDA-cleared, self-administered computerized cognitive assessment tools for the early detection of cognitive impairment, utilizing proprietary adaptive psychophysics technology to deliver reliable and customized patient experiences.

- Business Profile: https://optimly.ai/brand/cognivue
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://cognivue.com/
- Logo: https://logo.clearbit.com/cognivue.com
- Slug: cognivue
- Brand Authority Index tier: Emerging
- Archetype: Challenger
- Category: Healthcare
- Last Analyzed: August 9, 2026

## Buyer Intent Signals
Problems: Early detection of cognitive impairment | Addressing modifiable risk factors for cognitive decline | Bias in traditional cognitive assessment tools | Need for efficient and accessible cognitive screening
Solutions: Providing cognitive assessment tools | FDA-cleared adaptive psychophysics technology | Self-administered computerized assessment | Customized patient experience | Early detection capabilities (Clarity & Thrive) | Integration into healthcare workflows (Physicians, Hearing Healthcare, Pharmacy)
Comparisons: Clinical validity and reliability | Effectiveness compared to gold-standard tests (MoCA, SLUMS) | Sensitivity for detecting Mild Cognitive Impairment | Ease of use and workflow integration | Data points collected (130,000)